Summary
This business focuses on transforming canine cancer treatment through personalized medicine, utilizing genomic testing to identify specific cancer-causing mutations in dogs. By leveraging AI-driven precision medicine, they provide targeted therapy options that go beyond traditional chemotherapy and radiation, aiming to improve treatment outcomes for dogs diagnosed with cancer. The company has developed the largest proprietary cancer dataset in the world, which supports ongoing research and innovation in veterinary oncology.
Based on content on fidocure.com
foundationmedicine.com
Cambridge, MA
Molecular diagnostics and precision oncology.
cofactorgenomics.com
St. Louis, Missouri
Biotechnology and healthcare diagnostics.
We offer API access to our data.
8 of 8 checks passed
Label
Value
Active Dates
6.4 years — Since Aug 2018
Web Hosting
Platform
E-Mail Provider
Google GSuite
NAICS Code
541715
SIC 4 Digit Code
8731
SIC 2 Digit Code
87
Industry
1. Veterinary oncology and precision medicine.
2. Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Vendor
Source
Microsoft
TXT Record
GlobalSign
TXT Record
TXT Record
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2019 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2024 |
|
|
|
|
|
|
|
|
|
|
|
|